HOUSE 1188116th CongressReferred to the Subcommittee on Health.

FLAT Prices Act

Last Action: 2/14/2019

Actions

2019-02-14Referred to the Subcommittee on Health.
2019-02-13Referred to the House Committee on Energy and Commerce.
2019-02-13Introduced in House
2019-02-13Introduced in House

CRS Summary

As of 2019-02-13 (00)

Forcing Limits on Abusive and Tumultuous Prices or the FLAT Prices Act

This bill directs the Food and Drug Administration to reduce the market exclusivity of an approved prescription drug if the drug manufacturer increases the drug's price by more than a specified percentage. This reduction may be waived under specified circumstances.

Cosponsors (7)

Sean Casten (D-IL)
Elissa Slotkin (D-MI)
Gilbert Cisneros (D-CA)
Max Rose (D-NY)
Chellie Pingree (D-ME)
Abby Finkenauer (D-IA)
LLOYD DOGGETT (D-TX)

Subjects

Business records
Drug safety, medical device, and laboratory regulation
Government information and archives
Health care costs and insurance
Inflation and prices
Licensing and registrations
Prescription drugs

Read on Congress.gov

Sourced from Congress.gov (public domain).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.